Fundraise / allotmentFiled on BSE ·

Natco Pharma approves ₹1279.35 crore rights issue of 1.70 crore equity shares

Natco Pharma · Pharmaceuticals & Biotechnology

What the filing says

  • Rights issue price set at ₹750 per share including ₹748 premium; record date October 1, 2026
  • Rights issue opens October 12, 2026, closes October 22, 2026; on-market renunciation till October 16, 2026
  • Post-issue equity shares projected at 19.62 crore assuming full subscription; Board amends Code of Conduct for trading compliance

Original filing

Board Meeting Outcome for Out Come Of Board Meeting

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies

Electrical Equipment

Revenue: Rank 1Margin: Rank 1

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Natco Pharma

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.